| Product Name | MF | CAS | Details |
|---|
| MPO-IN-5 | C24H24N6O2 | 2476764-11-9 | Details |
| TGFβRI-IN-4 | C23H25F2N5O2 | 2421135-03-5 | Details |
| A1AR antagonist 3 | C25H20N2O3S | 2413257-73-3 | Details |
| MMP-2/9-IN-1 | C14H16IN7S | 2415311-84-9 | Details |
| Apoptosis inducer 10 | C27H46N2O2 | 2379310-39-9 | Details |
| Orexin receptor antagonist 3 | C21H22N8O3 | 1293282-55-9 | Details |
| Enpp-1-IN-4 | C19H19N5O5S | 2376600-89-2 | Details |
| MALT1-IN-8 | C20H15Cl2N7O | 2244109-29-1 | Details |
| Anti-infective agent 4 | C19H12F3N5O4 | 2738381-52-5 | Details |
| NS2B/NS3-IN-6 | C19H19N3O5S2 | 2459657-57-7 | Details |
| Anti-MRSA agent 2 | 2597082-01-2 | Details |
| RIPK1-IN-14 | 2919964-79-5 | Details |
| SARS-CoV-2 nsp13-IN-3 | C24H27N7O | 1015582-31-6 | Details |
| PARP-1/2-IN-1 | C24H27FN4O3 | 1903744-45-5 | Details |
| CBP/p300-IN-17 | C25H28N4O3 | 2259640-87-2 | Details |
| DM-01 | C23H24F3N3O2 | 2355280-00-9 | Details |
| S1p receptor agonist 2 | C24H23ClN2O4 | 1354908-17-0 | Details |
| Hydroxyethylamine | C25H41N3O3 | 1418733-36-4 | Details |
| CSF1R-IN-14 | C23H22F3N5O | 2361378-89-2 | Details |
| HBV-IN-17 | C17H15F6N5O2 | 2270943-13-8 | Details |
| 3,6-DMAD dihydrochloride | C22H32ClN5 | 2226511-77-7 | Details |
| RIPK3-IN-2 | C21H16ClN3O2S2 | 2665669-32-7 | Details |
| CXCR4 modulator-2 | C21H32N8O2 | 2488943-55-9 | Details |
| SV5 | C21H30N2O4S2 | 2581825-37-6 | Details |
| TRK-IN-17 | C21H21F2N7S | 2409544-80-3 | Details |
| GPR40 agonist 5 | C27H24N2O4 | 2443384-60-7 | Details |
| HBV-IN-10 | C23H24FN7O | 2716907-16-1 | Details |
| POP-IN-2 | C24H33BN2O5 | 2743432-81-5 | Details |
| AMG-8718 | C25H19FN4O3 | 1215868-94-2 | Details |
| THR-β agonist 1 | C17H14Cl2FN5O4 | 2648403-17-0 | Details |
| AChE-IN-15 | C23H24N2O7 | 2242792-25-0 | Details |
| HDAC-IN-46 | C22H30N8O2 | 2562386-85-8 | Details |
| CSF1R-IN-8 | C24H22N4O4 | 2765301-60-6 | Details |
| HBV-IN-14 | C22H21ClN2O5 | 2712529-19-4 | Details |
| GNF6702 | C22H16FN7O2 | 1799329-72-8 | Details |
| 14α-Demethylase/DNA Gyrase-IN-2 | C24H22N4O4 | 2330812-64-9 | Details |
| A2AAR/HDAC-IN-1 | C24H21N7O2 | 2767560-51-8 | Details |
| Tubulin polymerization-IN-18 | C25H25NO6 | 1258011-23-2 | Details |
| FAAH-IN-5 | C21H19N3O6S | 1338575-38-4 | Details |
| ATR-IN-17 | C22H28N6O2S | 2761194-15-2 | Details |
| CDK8-IN-7 | C30H40N2 | 2415156-30-6 | Details |
| RSV/IAV-IN-3 | C19H19BrN2O3S | 2395007-81-3 | Details |
| Nav1.8-IN-2 | C18H13Cl2F3N2O3 | 2756250-30-1 | Details |
| HDAC-IN-43 | C22H28N6O4 | 1809163-24-3 | Details |
| Enpp-1-IN-8 | C19H26N6O4S | 2718971-08-3 | Details |
| INCB38579 | C25H34N6O | 1246207-65-7 | Details |
| KH-3 | C21H22N2O4S2 | 1215115-03-9 | Details |
| QW30 | C27H36N2O3 | 1714112-25-0 | Details |
| Anti-MRSA agent 5 | C25H22N4O4 | 2490154-44-2 | Details |
| ALR1/2-IN-1 | C18H18N4O5S2 | 2419233-57-9 | Details |
| OBHS | C24H20O6S | 870614-18-9 | Details |
| CSF1R-IN-5 | C22H19N7O3 | 2716184-93-7 | Details |
| Antiproliferative agent-7 | C28H32N4O | 2497687-47-3 | Details |
| EGFR-IN-54 | C17H14N4O4S3 | 2418549-30-9 | Details |
| BChE-IN-9 | C30H51NO | 2468035-31-4 | Details |
| Antitrypanosomal agent 8 | C23H19N5O2S | 332376-42-8 | Details |
| PI3Kδ-IN-11 | C27H21N5O | 2413257-51-7 | Details |
| KB-5492 free base | C23H30N2O6 | 113594-64-2 | Details |
| Nivasorexant | C23H23N7O2 | 1435480-40-2 | Details |
| EGFR/BRAFV600E-IN-1 | C24H24ClN3O3 | 2492429-45-3 | Details |
| S100P-IN-1 | C25H16N2O6 | 690991-06-1 | Details |
| Tubulin polymerization-IN-20 | C25H24FNO5 | 2410619-45-1 | Details |
| BChE-IN-8 | C18H12BrN7O2 | 2653349-78-9 | Details |
| FGFR-IN-4 | C24H21N7O2 | 2761211-49-6 | Details |
| TRK-IN-13 | C24H21F2N5O | 1365221-52-8 | Details |
| ALK5-IN-27 | C25H28N8 | 2785430-83-1 | Details |
| (5S,8R)-HBV-IN-10 | C23H24FN7O | 2716907-15-0 | Details |
| JAK3/BTK-IN-4 | C21H25ClN8O | 2673196-38-6 | Details |
| NBD-14189 | C18H16F4N4O2S | 2234273-72-2 | Details |
| RORγt/DHODH-IN-2 | C25H30N4OS | 2641758-86-1 | Details |
| AChE-IN-14 | C28H35NO3 | 2390042-05-2 | Details |
| ANEB-001 | C22H24ClF3N2O2 | 791848-71-0 | Details |
| 3CPLro-IN-1 | C29H25NO3 | 2432956-06-2 | Details |
| VIM-2-IN-1 | C12H13IN4O4S | 2452118-54-4 | Details |
| Galectin-3-IN-1 | C18H26O10S | 1989627-40-8 | Details |
| S07-2008 | C21H23N3O5S | 1090816-80-0 | Details |
| SOS1-IN-12 | C23H26F3N5 | 2654741-56-5 | Details |
| SHR5133 | C19H18F4N6O2 | 2270943-23-0 | Details |
| CSF1R-IN-4 | C23H20N6O3 | 2716185-86-1 | Details |
| MIF-IN-3 | C20H20N4O5S | 2756410-83-8 | Details |
| EGFR-IN-56 | C23H22N4O3S | 2477726-83-1 | Details |
| TREM2 agonist-1 | C23H21ClFN5O | 2738486-70-7 | Details |
| IMPDH2-IN-2 | C21H15Cl2N3O3 | 1434517-02-8 | Details |
| CDK2-IN-11 | C18H14ClN7O2S | 2410402-82-1 | Details |
| ALK5-IN-25 | C23H23FN8 | 2785430-81-9 | Details |
| PI3K-IN-34 | C23H22N6O3 | 2458163-94-3 | Details |
| FGFR-IN-6 | C23H22N6O3 | 2762955-18-8 | Details |
| TRK-IN-14 | C24H21F2N5O | 1365212-84-5 | Details |
| Bcl-2/Mcl-1-IN-2 | C26H24ClNO3 | 2673361-07-2 | Details |
| Tubulin polymerization-IN-17 | C26H23NO5 | 2454175-89-2 | Details |
| ALK5-IN-32 | C23H23FN8 | 2785430-88-6 | Details |
| Anticancer agent 40 | C25H29NO6 | 2760658-33-9 | Details |
| hACC2-IN-1 | C23H32N2O4S | 192323-14-1 | Details |
| CB1/2 agonist 4 | C27H45NO3 | 2772949-38-7 | Details |
| RORγt inverse agonist 30 | C24H31N3O3S | 1445901-41-6 | Details |
| SGC agonist 1 | C22H19F2N7O | 1426309-31-0 | Details |
| ALK5-IN-31 | C23H23FN8 | 2785430-87-5 | Details |
| HPK1-IN-17 | C26H28N6O | 2403600-07-5 | Details |
| DX2-201 | C18H28N2O6S2 | 2749554-00-3 | Details |
| EGFR-IN-40 | C23H20N6O3 | 1466445-39-5 | Details |
| Product Total： Product Page： | ||||
| 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 | ||||